November 18, 2026
Health news, explained with evidence
LIVE

Probiotic Complex Shows Potential Benefits for Dry Eye Disease in Clinical Trial

🧠 AI Analysis 2 min read 👁 3

A recent randomized, double-blind trial published in Nature Health Sciences evaluated a specific probiotic blend for dry eye disease, showing improvements in tear stability.

🧠AI Analysis

Key points

  • Randomized, double-blind trial tested LB-101 probiotic complex in 80 adults with dry eye disease over eight weeks.
  • Participants taking the probiotic showed a significant improvement in tear break-up time compared to the placebo group.
  • Total OSDI scores and most objective surface endpoints showed no significant differences between groups.

Evaluating a Probiotic Approach for Ocular Health

Researchers at institutions including Samsung Medical Center and Kyung Hee University in Seoul investigated the effects of a probiotic complex, designated as LB-101 and containing Lactiplantibacillus plantarum NK151 and Bifidobacterium bifidum NK175, on adults suffering from dry eye disease (DED). The randomized, double-blind, placebo-controlled study enrolled 80 participants who received either the probiotic formulation or a placebo daily for eight weeks. Out of the initial group, 62 participants successfully completed the trial and were included in the final efficacy assessment.

Tear Stability Improvements and Symptom Measures

The trial found that individuals taking the LB-101 supplement experienced a statistically significant enhancement in tear break-up time compared to those in the placebo group, with a mean difference of 1.01 seconds. Furthermore, researchers noted notable improvements in specific individual symptom items measured by the Ocular Surface Disease Index (OSDI). However, the total OSDI scores and the majority of other objective ocular surface endpoints did not show significant differences between the two study arms. Exploratory analyses of the gut microbiota indicated an increase in Carnobacteriaceae and a reduction in endotoxin-producing Oxalobacteraceae among participants in the probiotic group, with no serious adverse events reported during the intervention period.

What to know: While the findings suggest that modulating the gut-eye axis may help improve tear film stability, the total symptom scores and most objective measures remained unchanged. Always consult a qualified physician before making decisions regarding dietary supplements or managing chronic health conditions.

Source Nature Health Sciences — nature.com/articles/s41598-026-79278-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.